Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports

Tachyarrhythmias are common complications of critically ill patients treated on intensive care units. Landiolol is an ultra-short acting beta-blocker with a very high beta1-selectivity. Therefore, landiolol effectively reduces heart rate with only minimal negative effects on blood pressure and inotr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangl, Clemens, Krychtiuk, Konstantin A, Schoenbauer, Robert, Speidl, Walter S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acute Optimization of Heart Rate in Atrial Fibrillation: Landiolol as a First Line Therapy Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190750/
https://www.ncbi.nlm.nih.gov/pubmed/35706896
http://dx.doi.org/10.1093/eurheartjsupp/suac026
Descripción
Sumario:Tachyarrhythmias are common complications of critically ill patients treated on intensive care units. Landiolol is an ultra-short acting beta-blocker with a very high beta1-selectivity. Therefore, landiolol effectively reduces heart rate with only minimal negative effects on blood pressure and inotropy. This article describes two cases of successful treatment of supraventricular and ventricular tachycardias with landiolol in critically ill patients.

Ejemplares similares